Search

Displaying results 9121 - 9130 of 10000 in total
  1. Drug

    Ecromeximab

    go.drugbank.com/drugs/DB12797
    Investigational

    Ecromeximab has been used in trials studying the treatment of Cutaneous Melanoma and Metastatic Melanoma.

  2. Drug

    Cebranopadol

    go.drugbank.com/drugs/DB12830
    Investigational

    Cebranopadol has been used in trials studying the treatment of Pain, Neoplasms, and Chronic Pain.

  3. Drug

    Chlorsulfaquinoxaline

    go.drugbank.com/drugs/DB12921
    Investigational

    Chlorsulfaquinoxaline has been used in trials studying the treatment of Lung Cancer and Colorectal Cancer.

  4. Drug

    Berkelium

    go.drugbank.com/drugs/DB12993
    Investigational

    Berkelium is under investigation in clinical trial NCT02189122 (Comparative Effects of Aspirin and NHP-544C).

  5. Drug

    MK-8245

    go.drugbank.com/drugs/DB13024
    Investigational

    MK-8245 has been used in trials studying the treatment of Type 2 Diabetes Mellitus.

  6. Drug

    Gossypol

    go.drugbank.com/drugs/DB13044
    Investigational

    Gossypol has been used in trials studying the treatment of Non-small Cell Lung Cancer.

  7. Drug

    Pruvanserin

    go.drugbank.com/drugs/DB13094
    Investigational

    Pruvanserin has been used in trials studying the treatment of Sleep Initiation and Maintenance Disorders.

  8. Drug

    Fialuridine

    go.drugbank.com/drugs/DB15427
    Investigational

    Fialuridine is under investigation in clinical trial NCT01337466 (Biodistribution and Dosimetry Evaluation of [124I]FIAU).

  9. Drug

    Imaradenant

    go.drugbank.com/drugs/DB16192
    Investigational

    Imaradenant is under investigation in clinical trial NCT03381274 (Oleclumab (MEDI9447) Egfrm NSCLC Novel Combination Study).

  10. Drug

    Phorbol 12-myristate 13-acetate diester

    go.drugbank.com/drugs/DB17045
    Investigational

    Phorbol 12-myristate 13-acetate diester is an inducer of neutrophil extracellular traps (NETs).[A253087]